Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00469911 · ClinicalTrials.gov registry record · NA

Quantification of Intramyocardial Lipid by Proton Magnetic Resonance Spectroscopy

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT00469911 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00469911, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

Accumulation of triglycerides in heart tissue has been associated with changes in left ventricular function which can lead to heart failure. Proton magnetic resonance spectroscopy is currently the only non-invasive in vivo method to measure myocardial triglycerides content. The primary goal of this study was to determine if Magnetic Resonance Spectroscopy could effectively measure myocardial triglyceride content in myocardial heart tissue. Thus, quantitative and reliable techniques to monitor in vivo triglyceride accumulation in the heart are important for disease diagnosis and management. Currently, no such imaging method exists.

Interventions

  • PROCEDURE Magnetic Resonance Spectroscopy
  • PROCEDURE Ex vivo heart biopsy

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2005-08
Est. Completion 2009-06
Phase NA

What the Registry Record Tells You About NCT00469911

The ClinicalTrials.gov registry entry for NCT00469911 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Spectroscopy is the first listed.

NCT00469911 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00469911 about?

NCT00469911 is a clinical study titled "Quantification of Intramyocardial Lipid by Proton Magnetic Resonance Spectroscopy". Accumulation of triglycerides in heart tissue has been associated with changes in left ventricular function which can lead to heart failure. Proton magnetic resonance spectroscopy is currently the only non-invasive in vivo method to measure myocardial triglycerides content. The primary goal of this ...

What is the current status of trial NCT00469911?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2005-08. Estimated completion is 2009-06.

What interventions are being tested in trial NCT00469911?

The interventions under investigation include: Magnetic Resonance Spectroscopy (PROCEDURE), Ex vivo heart biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT00469911?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.